Literature DB >> 6147246

In vitro activity of ticarcillin plus clavulanic acid against bacteria isolated in three centers.

A L Barry, L W Ayers, T L Gavan, E H Gerlach, R N Jones.   

Abstract

Over 10,000 bacterial isolates were tested against ticarcillin alone or combined with clavulanic acid (2.0 micrograms/ml). Of 5,295 Enterobacteriaceae, 72% were susceptible to ticarcillin alone, whereas 91% were susceptible to the combination. Bacteroides fragilis and Bacteroides melaninogenicus isolates were more susceptible to the combination. The activity of ticarcillin against other microorganisms was not profoundly influenced.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6147246     DOI： 10.1007/bf02014879

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN： 0722-2211            Impact factor:   3.267


  7 in total

1.  Combined activitiy of clavulanic acid and ticarcillin against ticarcillin-resistant, gram-negative bacilli.

Authors:  J W Paisley; J A Washington
Journal:  Antimicrob Agents Chemother       Date:  1978-08       Impact factor: 5.191

2.  Pharmacokinetics and tissue penetration of ticarcillin combined with clavulanic acid.

Authors:  S Bennett; R Wise; D Weston; J Dent
Journal:  Antimicrob Agents Chemother       Date:  1983-06       Impact factor: 5.191

3.  Susceptibility of gram-negative bacteria and Staphylococcus aureus to combinations of ticarcillin and clavulanic acid.

Authors:  P Casey; M Glauser
Journal:  Eur J Clin Microbiol       Date:  1983-12       Impact factor: 3.267

4.  In vitro synergistic properties of clavulanic acid, with ampicillin, amoxycillin and ticarcillin.

Authors:  P A Hunter; K Coleman; J Fisher; D Taylor
Journal:  J Antimicrob Chemother       Date:  1980-07       Impact factor: 5.790

5.  Clavulanic acid and CP-45,899: a comparison of their in vitro activity in combination with penicillins.

Authors:  R Wise; J M Andrews; K A Bedford
Journal:  J Antimicrob Chemother       Date:  1980-03       Impact factor: 5.790

6.  In vitro activity of ticarcillin plus clavulanic acid against 632 clinical isolates.

Authors:  P C Fuchs; A L Barry; C Thornsberry; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1984-03       Impact factor: 5.191

7.  In vitro evaluation of Augmentin by broth microdilution and disk diffusion susceptibility testing: regression analysis, tentative interpretive criteria, and quality control limits.

Authors:  P C Fuchs; A L Barry; C Thornsberry; T L Gavan; R N Jones
Journal:  Antimicrob Agents Chemother       Date:  1983-07       Impact factor: 5.191
  7 in total
  8 in total

1.  Discrepancies between disk diffusion and broth susceptibility studies of the activity of ticarcillin plus clavulanic acid against ticarcillin-resistant Pseudomonas aeruginosa.

Authors:  F A Manian; R H Alford
Journal:  Antimicrob Agents Chemother       Date:  1986-07       Impact factor: 5.191

Review 2.  Bacterial antibiotic resistance before and after clinical application in the United States.

Authors:  A L Barry; R N Jones
Journal:  Bull N Y Acad Med       Date:  1987-04

3.  [Pharmacokinetics of betabactyl in the field of gynecology].

Authors:  D v Kobyletzki; C A Primavesi; H D Heilmann; A Wieczorek; J Hofmann
Journal:  Arch Gynecol Obstet       Date:  1989       Impact factor: 2.344

Review 4.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

5.  Bactericidal effects of ticarcillin-clavulanic acid against beta-lactamase-producing bacteria in vivo.

Authors:  R J Boon; A S Beale; R Sutherland
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  Effect of clavulanic acid on the anti-pseudomonal activity of ticarcillin.

Authors:  M J Haverkorn
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-08       Impact factor: 3.267

7.  Characterization of a PSE-4 mutant with different properties in relation to penicillanic acid sulfones: importance of residues 216 to 218 in class A beta-lactamases.

Authors:  Y Sabbagh; E Thériault; F Sanschagrin; N Voyer; T Palzkill; R C Levesque
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

8.  Pharmacokinetics and tissue penetration of tazobactam administered alone and with piperacillin.

Authors:  R Wise; M Logan; M Cooper; J M Andrews
Journal:  Antimicrob Agents Chemother       Date:  1991-06       Impact factor: 5.191
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.